Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia

European Journal of Pediatrics

Volumn 155, Issue 2, 1996, Pages 81-86

  Mohnike, Klaus L ^a   Kluba, Ute ^a   Mittler, Uwe ^a   Aumann, Volker ^a   Vorwerk, Peter ^a   Blum, Werner F ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Growth regulation; Insulin like growth factor binding proteins; Insulin like growth factors; Leukaemia; Radioimmunoassay

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL PROLIFERATION; CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HUMAN; INFANT; LYMPHOBLAST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CELL DIVISION; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LEUKEMIA, LYMPHOCYTIC, ACUTE; PREDNISONE; VINCRISTINE;

EID: 0030054186     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02075755     Document Type: Article

References (55)

1. Adamo ML, Shao ZM, Lanau F, Chen JC, Clemmons DR, Roberts CTJ, LeRoith D, Fontana JA (1992) Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131: 1858-1866
2. Babajko S, Hardouin S, Segovia B, Groyer A, Binoux M (1993) Expression of insulin-like growth factor binding protein-1 and -2 genes through the perinatal period in the rat. Endocrinology 132: 2586-2592
3. Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82
4. Ballard J, Baxter R, Binoux M, Clemmons D, Drop S, Hall K, Hintz R, Rechler M, Rutanen E, Schwander J (1989) On the nomenclature of the IGF binding proteins [letter]. Acta Endocrinol Copenh 121: 751-752
5. Bar RS, Boes M, Clemmons DR, Busby WH, Sandra A, Dake BL, Booth BA (1990) Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 127: 497-499
6. Baserga R, Porcu P, Sell C (1993) Oncogenes, growth factors and control of the cell cycle. Cancer Surv 16: 201-213
7. Binoux M, Roghani M, Hossenlopp P, Hardouin S, Gourmelen M (1991) Molecular forms of human IGF binding proteins: physiological implications. Acta Endocrinol Copenh 124 [Suppl 2]: 41-47
8. Blum WF, Ranke MB, Bierich JR (1988) A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. Acta Endocrinol Copenh 118: 374-380
9. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR (1989) Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125: 766-772
10. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR (1990) A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70: 1292-1298
11. Blum WF, Ranke MB (1992) Insulin-like growth factors and their binding proteins. In: Blum WF, Ranke MB (eds) Functional endocrinologic diagnostics in children and adolescents. J and J Verlag. Mannheim, pp 102-118
12. Blum WF, Horn N, Kratzsch J, Jorgensen JO, Juul A, Teale D, Mohnike K, Ranke MB (199.3) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 3: 100-104
13. Breier BH, Milsom SR. Blum WF, Schwander J, Gallaher BW, Gluckman PD (1993) Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. Acta Endocrinol Copenh 129: 427-435
14. Brunner N, Yee D, Kern FG, Spang-Thomsen M, Lippman ME, Cullen KJ (1993) Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II). Eur J Cancer 29A: 562-569
15. Chard T, Blum WF, Brunjes J, Campbell DJ. Wathen NC (1994) Levels of insulin-like growth factor-binding protein-2 and insulin-like growth factor-II in maternal serum, amniotic fluid and extraembryonic coelomic fluid at 9-20 weeks of pregnancy. J Endocrinol 142: 379-383
16. Clemmons DR (1991) Insulin-like growth factor binding proteins: roles in regulating IGF physiology. J Dev Physiol 15: 105-110
17. Clemmons DR (1991) Insulin-like growth factor binding proteins. In: LeRoith D (ed) Insulin-like growth factors: molecular and cellular aspects. CRC Press, Ann Arbor, Boston, pp 151-180
18. Clemmons DR, Cascieri MA, Camacho-Hubner C, McCusker RH, Bayne ML (1990) Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. J Biol Chem 265: 12210-12216
19. Clemmons DR, Jones JI, Busby WH, Wright G (1993) Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann N Y Acad Sci 692: 10-21
20. Cohick WS, Clemmons DR (1993) The insulin-like growth factors. Annu Rev Physiol 55: 131-153
21. Dann MS, Lange MP, Jacobs LA (1988) Insulinlike growth factor 1 production is inhibited in human sepsis. Arch Surg 123: 1409-1414
22. Daughaday WH, Deuel TF (1991) Tumor secretion of growth factors. Endocrinol Metab Clin North Am 20: 539-563
23. Delhanty PJ, Han VK (1993) The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus. Endocrinology 132: 41-52
24. Delhanty PJ, Hill DJ, Shimasaki S, Han VK (1993) Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation? Growth Regul 3: 8-11
25. Drop SL (1991) Report on the nomenclature of te IGF binding proteins. Acta Endocrinol Copenh 125: 707-708
26. Gansler T, Furlanetto R, Gramling TS, Robinson KA, Blocker N, Buse MG, Sens DA, Garvin AJ (1989) Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice.
27. Gibson LF, Piktel D, Landreth KS (1993) Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82: 3005-3011
28. Han VK, D'Ereole AJ, Lund PK (1987) Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193-197
29. Humbel RE (1990) Insulin-like growth factors I and II. Eur J Biochem 190: 445-462
30. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A (1993) Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 77: 229-233
31. Lee PD, Rosenfeld RG, Hintz RL, Smith SD (1986) Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endocrinol Metab 62: 28-35
32. LeRoith D, Clemmons D, Nissley P, Rechter MM (1992) NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med 116: 854-862
33. LeRoith D, Adamo ML, Shemer J, Lanau F, Shen Orr Z, Yaron A, Roberts CT, Jr., Clemmons DR, Sheikh MS, Shao ZM, et al (1993) Retinoic acid inhibits growth of breast cancer cell lines: the role of insulin-like growth factor binding proteins. Growth Regul 3: 78-80
34. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igt-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72
35. McGuire WLJ, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D (1992) Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst 84: 1336-1341
36. Minniti CP, Maggi M, Helman LJ (1992) Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop. Cancer Res 52: 1830-1835
37. Mishra L, Voyles N, Bass B, et al (1993) Gene expression of IGFBP-2 is increased in human colorectal carcinoma. [Abstract] FASEB J 7: 2166
38. Moser DR, Lowe WL Jr, Dake BL, Booth BA, Boes M, Clemmons DR, Bar RS (1992) Endothelial cells express insulin-like growth ractor-binding proteins 2 to 6. Mol Endocrinol 6: 1805-1814
39. Muller HL, Oh Y, Gargosky SE, Wilson KF, Lehrnbecher T, Rosenfeld RG (1994) Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemia. Pediatr Res 35: 720-724
40. Nakatani A, Shimasaki S, Erickson GF, Ling N (1991) Tissue-specific expression of four insulin-like growth factor-binding proteins (1,2, 3, and 4) in the rat ovary. Endocrinology 129: 1521-1529
41. Nyman T, Pekonen F (1993) The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol Copenh 128: 168-172
42. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362: 749-751
43. Orlowski CC, Brown AL, Ooi GT, Yang YW, Tseng LY. Rechler MM (1990) Tissue, developmental, and metabolic regulation of messenger ribonucleic acid encoding a rat insulin-like growth factor-binding protein. Endocrinology 126: 644-652
44. Rechler MM (1993) Insulin-like growth factor binding proteins. Vitam Horm 47: 1-114
45. Reiss K, Porcu P, Sell C, Pietrzkowski Z, Baserga R (1992) The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene 7: 2243-2248
46. Ren-Qiu Q, Ruelicke T, Hassam S, Haselbacher GK, Schoenle EJ (1993) Systemic effects of insulin-like growth factor-II produced and released from Wilms tumour tissue. Eur J Pediatr 152: 102-106
47. Rutanen EM, Stenman S, Blum W, Karkkainen T, Lehtovirta P, Stenman UH (1993) Relationship between carbohydrate metabolism and serum insulin-like growth factor system in post-menopausal women: comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab 77: 199-204
48. Sauerbrey A, Zintl F, Malke H, Reimann M, Maaser M, Domula M, Dorffel W, Eggers G, Exadaktylos P, Kotte W et al (1993) Results and experiences with a modified BFM protocol tor treatment of recurrences in children with acute lymphoblastic leukemia in East German areas. Klin Padiatr 205: 281-287
49. Smith SD, McFall P, Morgan R, Link M, Hecht F, Cleary M, Sklar J (1989) Long-term growth of malignant thymocytes in vitro. Blood 73: 2182-2187
50. Timme J, Mittler U, Mohnike K, Dörffel W. Einfluss verschiedener Therapie-protokolle auf das Wachstum und die Endgrösse von Kindern mit akuter lymphoblastischer Leukämie oder Non-Hodgkin-Lymphom. Klin Pad (in press)
51. Van der Does-van den Berg A, Bartram CR, Basso G, Benoit YC, Biondi A, Dehatin KM, Haas OA, Harbott J, Kamps WA, Koller U, et al ( 1992) Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med Pediatr Oncol 20: 497-505
52. Wood TL, Streck RD, Pintar JE (1992) Expression of the IGFBP-2 gene in post-implantation rat embryos. Development 114: 59-66
53. Yateman ME, Claffey DC, Cwyfan Hughes SC, Frost VJ, Wass JA, Holly JM (1993) Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. J Endocrinol 137: 151-159
54. Zhang LQ, Downie PA, Goodell WR, McCabe NR, LeBeau MM, Morgan R, Sklar J, Raimondi SC, Miley D, Goldberg A, et al (1993) Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia. Leukemia 7: 1865-1874
55. Zumkeller W. Schwander J, Mitchell CD, Morrell DJ, Schofield PN, Preece MA (1993) Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour. Eur J Cancer 29A: 1973-1977